ATE136778T1 - Oral anzuwendende arzneimittel dapiprazol enthaltend - Google Patents

Oral anzuwendende arzneimittel dapiprazol enthaltend

Info

Publication number
ATE136778T1
ATE136778T1 AT92202219T AT92202219T ATE136778T1 AT E136778 T1 ATE136778 T1 AT E136778T1 AT 92202219 T AT92202219 T AT 92202219T AT 92202219 T AT92202219 T AT 92202219T AT E136778 T1 ATE136778 T1 AT E136778T1
Authority
AT
Austria
Prior art keywords
dapiprazole
products containing
medicinal products
oral medicinal
granulate
Prior art date
Application number
AT92202219T
Other languages
English (en)
Inventor
Angeli Depalmo Galli
Leandro Baiocchi
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Application granted granted Critical
Publication of ATE136778T1 publication Critical patent/ATE136778T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT92202219T 1991-07-24 1992-07-18 Oral anzuwendende arzneimittel dapiprazol enthaltend ATE136778T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912044A IT1250701B (it) 1991-07-24 1991-07-24 Composizione farmaceutica solida per uso orale a base di dapiprazolo

Publications (1)

Publication Number Publication Date
ATE136778T1 true ATE136778T1 (de) 1996-05-15

Family

ID=11360418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92202219T ATE136778T1 (de) 1991-07-24 1992-07-18 Oral anzuwendende arzneimittel dapiprazol enthaltend

Country Status (9)

Country Link
US (1) US5234927A (de)
EP (1) EP0524696B1 (de)
JP (1) JP3330977B2 (de)
AT (1) ATE136778T1 (de)
BG (1) BG61242B2 (de)
CA (1) CA2074580C (de)
DE (1) DE69209916T2 (de)
DK (1) DK0524696T3 (de)
IT (1) IT1250701B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (de) * 1992-07-30 1996-03-01 Pfizer
US6187774B1 (en) 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
US6730691B1 (en) 2000-02-10 2004-05-04 Miles A. Galin Uses of alpha adrenergic blocking agents
PT1421944E (pt) 2001-08-27 2008-01-03 Kyowa Chem Ind Co Ltd Comprimidos antiácidos e laxantes que compreendem óxido demagnésio
WO2008033024A2 (en) * 2006-09-15 2008-03-20 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
AU2007295178B2 (en) * 2006-09-15 2013-04-18 Echo Pharmaceuticals B.V. Granulate containing a pharmaceutically active substance and anemulsifier and method for its manufacture

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1209634A (en) * 1967-06-29 1970-10-21 Rit Rech Ind Therapeut Stabilized antibiotic compositions for animal feeding and process for preparing them
IT1094076B (it) * 1978-04-18 1985-07-26 Acraf Cicloalchiltriazoli
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
US4879304A (en) * 1987-05-01 1989-11-07 Angelini Pharmaceuticals Ltd. Ophthalmic compositions and process for preparing
US4879294A (en) * 1988-01-28 1989-11-07 Angelini Pharmaceuticals Ltd. Opthalmic composition
IT1224250B (it) * 1988-06-10 1990-09-26 Acraf Associzione del depiprazolo con la morfina

Also Published As

Publication number Publication date
CA2074580A1 (en) 1993-01-25
IT1250701B (it) 1995-04-21
US5234927A (en) 1993-08-10
ITMI912044A1 (it) 1993-01-25
DE69209916T2 (de) 1996-12-05
CA2074580C (en) 2002-12-10
JPH05194228A (ja) 1993-08-03
EP0524696B1 (de) 1996-04-17
DK0524696T3 (da) 1996-08-12
ITMI912044A0 (it) 1991-07-24
JP3330977B2 (ja) 2002-10-07
DE69209916D1 (de) 1996-05-23
BG61242B2 (bg) 1997-03-31
EP0524696A1 (de) 1993-01-27

Similar Documents

Publication Publication Date Title
IL96900A0 (en) Pharmaceutical composition containing naproxen
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
ZA874577B (en) New galenic formulations with programmed release containing antiphlogistics
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ATE130758T1 (de) Arzneimittel zur intranasalen verabreichung, die ketorolac r enthalten.
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
IL85523A (en) Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
CA2102630A1 (en) Pharmaceutical compositions of compacted medicaments
DK0510404T3 (da) Gastroresistente farmaceutiske formuleringer til oral administration indeholdende galdesyresalte
CA2039197A1 (en) Pharmaceutic Formulation for the Treatment of Alcoholism
ATE77236T1 (de) Pharmazeutische zusammensetzungen.
AU8188691A (en) The use of inositoltrisphosphate for the preparing of medicaments
TW221378B (de)
AU4786396A (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
CA2046069A1 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ATE136778T1 (de) Oral anzuwendende arzneimittel dapiprazol enthaltend
IT1204400B (it) Composizioni farmaceutiche contenente una calcitonina
DE69123190D1 (de) Hirudin enthaltende orale Arzneimittel
DK0483320T3 (da) Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
EP0523013A3 (de) Verwendung von Benzimidazolin-2-oxo-1-Carbonsäurederivaten bei der Behandlung organischer Gehirnerkrankungen
ATE181828T1 (de) Oral anzuwendendes arzneimittel bestehend aus ibuprofen
DE3265827D1 (en) Pharmaceutical composition of phosphonomicin in tablet form
JPS57126422A (en) Stabilizing method of lysozyme pharmaceutical
EP0367509A3 (de) Formulierungen

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee